National Health Investors (NHI) Upgraded by Zacks Investment Research to Hold

This post was originally published on this site

National Health Investors stock has undergone multiple analysts rating changes in the recent past.  National Health Investors Upgraded by Zacks Investment Research on 10/12/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

Shares of National Health Investors traded up $0.36 on Monday, reaching $52.87. 0 shares of the stock traded hands, compared to its average volume of 340626. Shares of National Health Investors were trading at $52.87 on Monday. The firm’s 50 day moving average is $59.09 and its 200 day moving average is $66.85.National Health Investors has a 12 month low of $52.30 and a 12 month high of $78.56. While on yearly highs and lows, National Health Investors’s today has traded high as $53.08 and has touched $52.30 on the downward trend. See More Analyst Rating at: RATING

National Health Investors Earnings and What to expect: 

National Health Investors last posted its quarterly earnings data on August 9th, 2021. The real estate investment trust reported $0.85 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.25 by $0.40. The firm earned $74.33 million during the quarter, compared to analyst estimates of $77.22 million. Its revenue for the quarter was down 11.7% compared to the same quarter last year. National Health Investors has generated $5.60 earnings per share over the last year ($3.41 diluted earnings per share) and currently has a price-to-earnings ratio of 15.5. Earnings for National Health Investors are expected to grow by 4.33% in the coming year, from $5.08 to $5.30 per share. National Health Investors has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, November 8th, 2021 based off prior year’s report dates.

Earnings for National Health Investors are expected to grow by 4.33% in the coming year, from $5.08 to $5.30 per share. The P/E ratio of National Health Investors is 15.50, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.28. The P/E ratio of National Health Investors is 15.50, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 13.13. National Health Investors has a P/B Ratio of 1.55. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

National Health Investors (NHI) Moving Average Technical Analysis

5 day Moving Average is $52.71 And 5 day price change is -$1.15 (-2.13%)  with average volume for 5 day average is 330,760. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $55.14 and 20 day price change is -$5.97 (-10.15%) and average 20 day moving volume is 370,120. 50 day moving average is $59.09  and 50 day price change is -$15.36 ( -22.51%)  and with average volume for 50 days is : 323,982. 200 day moving average is $66.85  and 200 day price change is -$16.68 (-23.98%)  and with average volume for 200 days is : 310,946.

Other owners latest trading in National Health Investors :

  • On 10/7/2021 shares held by State of Alaska Department of Revenue were 22,500 which equates to market value of $1.20M and appx 0.00% owners of National Health Investors
  • On 10/6/2021 shares held by Pensionfund Sabic were 19,600 which equates to market value of $1.05M and appx 0.20% owners of National Health Investors
  • On 9/13/2021 shares held by Bank of America Corp DE were 715,650 which equates to market value of $47.98M and appx 0.00% owners of National Health Investors
  • In total Institutional ownership equates to Institutional Ownership Percentage: 63.97% for National Health Investors

See More Analyst Rating at: RATING